Journal
ANTIOXIDANTS
Volume 10, Issue 11, Pages -Publisher
MDPI
DOI: 10.3390/antiox10111695
Keywords
blood-brain barrier; oxidative stress; insulin resistance; diabetes mellitus; Alzheimer's disease
Funding
- National Institute of Health [P30 DK017047-44, 1P30AG066509-01]
- Veterans Affairs Puget Sound Health Care System Research and Development
Ask authors/readers for more resources
The blood-brain barrier serves as a crucial interface between the periphery and the central nervous system, protecting the CNS from oxidative stress. The impact of oxidative stress on brain endothelial cells can disrupt insulin signaling, leading to disease development in conditions like diabetes mellitus and Alzheimer's disease.
The blood-brain barrier (BBB) is a network of specialized endothelial cells that regulates substrate entry into the central nervous system (CNS). Acting as the interface between the periphery and the CNS, the BBB must be equipped to defend against oxidative stress and other free radicals generated in the periphery to protect the CNS. There are unique features of brain endothelial cells that increase the susceptibility of these cells to oxidative stress. Insulin signaling can be impacted by varying levels of oxidative stress, with low levels of oxidative stress being necessary for signaling and higher levels being detrimental. Insulin must cross the BBB in order to access the CNS, levels of which are important in peripheral metabolism as well as cognition. Any alterations in BBB transport due to oxidative stress at the BBB could have downstream disease implications. In this review, we cover the interactions of oxidative stress at the BBB, how insulin signaling is related to oxidative stress, and the impact of the BBB in two diseases greatly affected by oxidative stress and insulin resistance: diabetes mellitus and Alzheimer's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available